SAN FRANCISCO, Jan. 25, 2010 (GLOBE NEWSWIRE) -- YesDTC Holdings, Inc. (OTCBB:YESD), a direct-to-consumer global distributor and marketer of consumer goods and products, announces the Company has successfully completed negotiations with BioElectronics, Corp. (Pink Sheets:BIEL) to begin distribution of the award-winning ActiPatch™ Therapy disposable drug-free anti-inflammatory device throughout Japan.
Under the terms of the arrangement, YesDTC will hold full television, direct-to-consumer and retail distribution rights to consumers within the world's second largest economy. YesDTC plans to initially launch distribution through direct response television advertising and is currently formulating plans for retail launch. ActiPatch is currently categorized within Japan as a Class I medical device.
"We are looking forward to working closely with everyone at BioElectronics to launch distribution into what will likely become a very significantly sized market for the ActiPatch Therapy brand," commented Joe Noel, CEO of YesDTC Holdings, Inc. "We have already placed a substantial order with BioElectronics and expect product shipments from the Company over the short term. In order to address the Japanese market we are aligning ourselves with some of the most successful marketers within the direct response television and retailing marketplaces and because the product is categorized within Japan as a Class I device, we believe we will be able to enter this market very quickly. We are very excited about the initial responses we have received relative to the drug-free nature of this product and believe the Japanese consumer, who is much more accustomed and accepting of bioelectric therapies, will be very receptive to this product offering. We plan to move aggressively into this marketplace."
About YesDTC Holdings, Inc.
YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), Internet and retail marketing programs. The Company brings a unique set of skills to this marketplace. YesDTC combines both creative talents and financial acumen to create a total package for direct-to-consumer marketing programs. We have formed a strategic partnership with Schulberg Media Works (SMW), one of the pioneering firms in the direct-to-consumer space. SMW's track record is impressive with nearly $1 billion in revenues and a strong track record of industry awards. SMW campaigns include Tempur-Pedic, Guthy-Renker, Sony, 24-Hour Fitness, Rhino Records, HarperCollins, PureSleep, among many others.
About BioElectronics Corporation
BioElectronics Corporation is the maker of ActiPatch(R) Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.
Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" that involve risks and uncertainties. These include statements about our expectations, plans, objectives, assumptions or future events. You should not place undue reliance on these forward-looking statements. Information concerning factors that could cause our actual results to differ materially from these forward-looking statements can be found in our periodic reports filed with the Securities and Exchange Commission. We undertake no obligation to publicly release revisions to these forward-looking statements to reflect future events or circumstances or reflect the occurrence of unanticipated events.